Corn diseases lurk in bumper US crop, threatening yields
On Sept. 12, 2025, high levels of fungal disease are lurking in corn fields across the U.S. Midwest,…
-
-
3D bioprinted mini placentas could transform pregnancy research
On Sept. 12, 2025, scientists from the University of Technology Sydney (UTS) announced they have achieved a major…
-
Melinda French Gates launches $100 million push for women’s health research
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
-
Merck to scrap London drug research centre
On Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
-
Utah Health Officials Report Large Measles Exposure
On Sept. 10, 2025, the Utah Department of Health and Human Services (UDOH) reported a potential large exposure…
-
UK trial launches to transform Alzheimer’s diagnosis with simple blood test
On Sept. 10, 2025, a major University of London (UCL)-led clinical trial, aiming to transform the diagnosis of…
-
NASA’s Mars Rover Discovered Potential Biosignature
On Sept. 10, 2025, the National Aeronautics and Space Administration (NASA) announced that a sample collected by NASA’s…
-
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
On Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…
-
Novartis to acquire Tourmaline Bio and pipeline for atherosclerotic cardiovascular disease, valued at $1.4 Billion
On Sept. 9, 2025, Novartis announced that it has entered into an agreement to acquire Tourmaline Bio, a…
-
Emergent BioSolutions Receives New Contract for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
On Sept. 9, 2025, Emergent BioSolutions announced that a contract modification has been executed in the amount of…
-
Lilly launches TuneLab platform to give biotech companies access to AI-enabled drug discovery models with over $1 billion in research investment
On Sept. 9, 2025, Eli Lilly announced the launch of Lilly TuneLab, an artificial intelligence and machine learning…
-
Elutia Announces Sale of BioEnvelope Business to Boston Scientific for $88 Million
On Sept. 9, 2025, Elutia announced it has entered into a definitive agreement to sell its EluPro™ and…
-
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
On Sept. 8, 2025, Pfizer and BioNTech announced positive topline results from an ongoing Phase 3 clinical trial…
-
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
On Sept. 8, 2025, Femasys announced it has received approval from the New Zealand Medicines and Medical Devices…
-
eGenesis Announces IND Clearance for EGEN-2784 in Pig Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study
On Sept. 8, 2025, eGenesis announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
-
Nearly half of people with diabetes don’t realize they have the disease
On Sept. 8, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
-
Study Led by Roswell Park Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
On Sept. 8, 2025, research led by Sai Yendamuri, MD, MBA, FACS, Chair of Thoracic Surgery at Roswell…
-
Mpox outbreak in Africa is no longer a global health emergency
On Sept. 5, 2025, the World Health Organization announced that it no longer considers the mpox outbreak in…
-
Hope for diabetes: CRISPR-edited cells pump out insulin in a person — and evade immune detection
On Sept. 5, 2025, in a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into…
-
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine | Women's Health
Washington State Department of Health confirms COVID-19 vaccine position with Standing Order
On Sept. 5, 2025, The Washington State of Health (DOH) issued a Standing Order for the COVID-19 vaccine,…
-
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
Hawaii to join West Coast Health Alliance with California, Oregon, and Washington
On Sept. 4, 2025, roughly 24 hours after the launch of the West Coast Health Alliance, Hawaii is…
-
Stealthy Spacecraft Bacteria Can Play Dead to Survive
On Sept. 4, 2025, a University of Houston lead team announced research showing that a bacterial species found…
-
Democratic Republic of the Congo Declares Ebola Virus Outbreak
On Sept. 4, 2025, Health authorities in the Democratic Republic of the Congo have declared an outbreak of…
-
Biological ‘moonshot’ accelerates efforts to genetically map life on earth
On Sept. 4, 2025, a global collaboration that includes experts at the Wellcome Sanger Institute announced mapping out…
-
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
On Sept. 4, 2025, Revvity announced the opening of its new In Vivo Imaging Center of Excellence in…
-
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
On Sept. 4, 2025, Novavax announced a milestone payment from Takeda has been triggered by regulatory approval for Novavax’s…
-
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
California, Oregon, and Washington to launch new West Coast Health Alliance to uphold scientific integrity in public health as Trump destroys CDC’s credibility
On Sept. 3, 2025, California Governor Gavin Newsom, Oregon Governor Tina Kotek, and Washington Governor Bob Ferguson announced…
-
Complete brain activity map revealed for the first time
On Sept. 3, 2025, The International Brain Laboratory (IBL) researchers published their findings today in two papers in Nature, revealing…
-
Golden Goose Award Honors Federally Funded Breakthroughs in Cancer Treatments and Disease Diagnostics
On Sept. 3, 2025, The Golden Goose Award, which spotlights obscure, silly sounding or odd fundamental discovery research that…
-
C2N Diagnostics Expands St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
